Accurate Charge Profiling and Characterization for Biopharmaceuticals
Understanding the charge profile heterogeneity of therapeutic proteins is a critical part of biopharmaceutical structural and physicochemical characterization as required by ICH Topic Q6B. Charge variants can arise from post-translational modifications (PTMs) such as deamidation, glycosylation (glycoform) via sialylation heterogeneity and from heavy chain C-terminal lysine processing in monoclonal antibodies (mAbs), all of which impact stability, efficacy and regulatory compliance.
BioPharmaSpec provides expert-driven charge isoform analysis services, utilizing imaging capillary IsoElectric Focusing (icIEF), preparative icIEF fractionation (followed by characterization of the collected fragments) and Ion Exchange Chromatography (IEX) to generate high-resolution charge profiles. Our approach ensures:
- Lot-to-lot consistency & stability monitoring.
- Biosimilar comparability.
- Assessment of purity and detection of impurities & product degradation markers.
We act as an extension of your team, delivering fast, accurate results that drive better decision-making in biopharmaceutical development.
Why Choose Biopharmaspec?
- Expert Scientists: Our team of highly trained specialists will develop and optimize the analysis and fractionation, if required, and accurately interpret the complex analytical data to deliver actionable insights.
- End-to-End Support: We provide a consultative approach, guiding clients from method selection through execution and result interpretation, ensuring clarity and confidence in decision-making.
- Regulatory Alignment: Our projects are designed to fulfil the requirements of ICH Q6B guidelines.
- International Laboratory Network: Wherever you are, BioPharmaSpec offers access to high-quality analytical services through our labs in the United States, United Kingdom, Germany, Italy, and Lithuania.
Why Charge Variant Profiling Matters
- Regulatory Requirement: Charge variant profiling is required for ICH Q6B compliance and global regulatory approvals.
- Biopharmaceutical Stability: PTMs such as deamidation, phosphorylation, proteolytic processing and glycosylation can alter charge states and affect drug stability.
- Biosimilar Comparability: Charge profiles must align with reference products for biosimilar development.
- Purity & Process Monitoring: Charge isoform analysis ensures batch consistency, detects unexpected impurities, and supports process optimization.
Our Charge Profiling Approach
1. icIEF for High-Resolution Separation
We use Imaged Capillary Isoelectric Focusing (icIEF) on the MauriceFlex (Bio-techne) system to achieve high-resolution separation of charge variants, enabling:
- High Sensitivity & Resolution: Leverages whole column imaging detection to detect subtle charge differences with minimal sample preparation.
- Fast Turnaround: icIEF separation provides charge profile data in minutes, allowing high throughput analysis and rapid decision-making.
- Fraction Collection: For further in-depth characterization using the Maurice Flex system
- Comparability Assessments: Essential for biosimilar and innovator characterization.
Representative icIEF analysis of Rituxan, illustrating charge heterogeneity and charge variant detection. The peaks at pI 6.1 and 10.1 serve as internal markers, ensuring accuracy.
2. Ion Exchange Chromatography (IEX) for Fraction Collection
While icIEF provides exceptional resolution, IEX is an orthogonal technique for charge-based profiling and also allows for charge-based isoform collection.
BioPharmaSpec uses IEX chromatographic separation in parallel to icIEF analysis to provide charge profiling and isoform collection using the most appropriate approach for your product.
- Isoform Collection: Enables fractionation of protein charge variants for further mass spectrometry (MS) or structural analysis.
- Orthogonal Data Validation: Cross-confirmation with techniques such as peptide mapping and molecular weight analysis.
- Expanded Characterization: Supports a more complete understanding of charge heterogeneities and their potential impact on drug function and stability.
3. MS Detection for Advanced Charge Variant Characterization
While icIEF and IEX provide high-resolution separation and fraction collection, integrating mass spectrometry (MS) with icIEF or IEX further enhances charge variant characterization. This approach enables:
- Accurate identification of charge variants by confirming structural differences at the molecular level.
- Greater specificity in peak identification, overcoming the limitations of traditional icIEF and/or IEX alone.
- Comprehensive biosimilar comparability, ensuring regulatory compliance and process optimization.
At BioPharmaSpec, we provide mass spectrometric characterization alongside icIEF and IEX to give clients a complete analytical picture of their biopharmaceuticals. This integration ensures a deeper understanding of protein charge heterogeneity and supports informed decision-making in drug development.
![Charge isoforms Fig 1 C-terminal Lysine para[1]](https://biopharmaspec.com/wp-content/uploads/2020/10/Charge-isoforms-Fig-1-C-terminal-Lysine-para1.svg "Charge isoforms Fig 1 C-terminal Lysine para[1]")
Imaged Capillary Isoelectric Focusing (icIEF) electropherogram of an IgG before (A) and after (B) treatment with carboxypeptidase B to remove C-terminal lysine. The absence of lysine-containing components (arrowed) after treatment highlights charge profile shifts, confirming variant removal. More acidic peaks correspond to deamidated species. Peaks “I” and “M” indicate the main monoclonal antibody variant and a pI marker, respectively.
Common Charge Variants We Analyze
| C-terminal Lysine (mAbs) | Increases pI values, alters stability & efficacy. Charge profiling assesses variant presence and its potential impact on product consistency. |
| Deamidation | Decreases pI, signals protein stress & degradation. A key indicator of product instability, requiring monitoring during manufacturing & storage. |
| Glycosylation Variants | Sialylation (sialic acids) increases acidity and impacts biological function & half-life through the asialoglycoprotein receptor in the liver. Charge profiling helps assess glycan composition & therapeutic performance. |
| Phosphorylation | Modifies protein charge & cellular function, affecting mechanism of action. |
Get Expert Charge Variant Analysis Today
Ensure the consistency, stability, and regulatory guideline compliance of your biopharmaceuticals with expert-driven charge isoform analysis. Our scientists provide accurate IEX separation in parallel to icIEF analysis with advanced mass spectrometric structural analysis to support your biopharmaceutical development and manufacturing needs.